Page 163 - Materials Chemistry, Second Edition
P. 163

L1644_C04.fm  Page 135  Tuesday, October 21, 2003  3:13 PM









                             (polyaromatic hydrocarbons). Potential cancer risk factors are determined by both
                             approaches and both types of damage functions are important sources of uncertain-
                             ties — especially the question of extrapolation to lower doses and the correlations
                             made implying insecurity.

                             4.6.1  HUMAN HEALTH DOSE–RESPONSE AND EXPOSURE RESPONSE

                             Government agencies are charged with the protection of the public health and
                             ecology; however, the U.S. Environmental Protection Agency (USEPA), the Agency
                             for Toxic Substances and Disease Registry (ATSDR), and the U.S. Food and Drug
                             Administration (FDA) must have a reference, or comparison value, upon which to
                             base an evaluation of potential health threats posed by any substances or chemicals.
                             The bases, or starting points, for such estimations may have different names or
                             acronyms but they represent more or less the same thing. The risk of carcinogenic
                             pollutants is estimated with a factor of potential cancer; however, the risk of non-
                             carcinogenic pollutants is characterized by a reference dose. These values for non-
                             carcinogenic endpoints are called oral reference doses (RfDs) and inhalation refer-
                             ence concentrations (RfCs) by the USEPA, acceptable daily intakes (ADIs) by the
                             FDA, and oral and inhalation minimal risk levels (MRLs) by ATSDR (Table 4.2).




                             TABLE 4.2
                             Oral RfDs/ADIs/MRLs for Noncarcinogenic Effects of Some Different
                             Chemicals

                              Regulated substance  RfDs (mg/kg-day)  ADIs (mg/kg-day)  MRLs (mg/kg-day)
                             Acetone                0.100           0.1         Oral int. 2
                             Cadmium                0.0005          5.10 –4     Oral chr. 0.0002
                             Chloroform             0.010           0.01        Oral acute 0.3
                                                                                Oral int. 0.1
                                                                                Oral chr. 0.01
                             1,1-Dichloroethylene   0.009           0.009       Oral chr. 0.009
                             Cis-1,2-Dichloroethylene  0.010        0.01        Oral acute 1
                                                                                Oral int. 0.3
                             Methylene chloride     0.060           0.06        Oral acute 0.2
                                                                                Oral chr. 0.06
                             Tetrachloroethylene    0.010           0.01        Oral acute 0.2
                                                                                Oral chr. 0.06
                             Toluene                0.200           0.3         Oral acute 0.8
                                                                                Oral int. 0.02
                             1,1,1-Trichloroethane  0.035           0.09        Inhalation acute 2 ppm a
                                                                                Inhalation int. 0.7 ppm
                             Xylene                 2.000           2.0         Oral int. 0.2
                             a Just available inhalation effects.
                             Note: Oral RfDs and ADIs refer to chronic effects. MRL values refer to intense, acute and chronic
                              effects.


                             © 2004 CRC Press LLC
   158   159   160   161   162   163   164   165   166   167   168